Correlation Between MediciNova and Inozyme Pharma
Can any of the company-specific risk be diversified away by investing in both MediciNova and Inozyme Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MediciNova and Inozyme Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MediciNova and Inozyme Pharma, you can compare the effects of market volatilities on MediciNova and Inozyme Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MediciNova with a short position of Inozyme Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of MediciNova and Inozyme Pharma.
Diversification Opportunities for MediciNova and Inozyme Pharma
-0.21 | Correlation Coefficient |
Very good diversification
The 3 months correlation between MediciNova and Inozyme is -0.21. Overlapping area represents the amount of risk that can be diversified away by holding MediciNova and Inozyme Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inozyme Pharma and MediciNova is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MediciNova are associated (or correlated) with Inozyme Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inozyme Pharma has no effect on the direction of MediciNova i.e., MediciNova and Inozyme Pharma go up and down completely randomly.
Pair Corralation between MediciNova and Inozyme Pharma
Given the investment horizon of 90 days MediciNova is expected to generate 3.15 times more return on investment than Inozyme Pharma. However, MediciNova is 3.15 times more volatile than Inozyme Pharma. It trades about 0.14 of its potential returns per unit of risk. Inozyme Pharma is currently generating about -0.73 per unit of risk. If you would invest 163.00 in MediciNova on August 28, 2024 and sell it today you would earn a total of 42.00 from holding MediciNova or generate 25.77% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
MediciNova vs. Inozyme Pharma
Performance |
| Timeline |
| MediciNova |
| Inozyme Pharma |
MediciNova and Inozyme Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with MediciNova and Inozyme Pharma
The main advantage of trading using opposite MediciNova and Inozyme Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MediciNova position performs unexpectedly, Inozyme Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inozyme Pharma will offset losses from the drop in Inozyme Pharma's long position.| MediciNova vs. Aerovate Therapeutics | MediciNova vs. Adagene | MediciNova vs. Acrivon Therapeutics, Common | MediciNova vs. Rezolute |
| Inozyme Pharma vs. Eliem Therapeutics | Inozyme Pharma vs. HCW Biologics | Inozyme Pharma vs. Scpharmaceuticals | Inozyme Pharma vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |